MNST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Monster Beverage Corp (MNST) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, consistent analyst upgrades, and robust growth trends outweigh the short-term technical weakness and insider/hedge fund selling. The stock's long-term growth potential, supported by its clean balance sheet and international expansion, aligns well with a long-term investment strategy.
The technical indicators present a mixed picture. While the MACD is negative and contracting (-0.253), suggesting bearish momentum, the RSI is neutral at 52.424. The moving averages (SMA_5 > SMA_20 > SMA_200) are bullish, indicating an upward trend. Key support is at $79.94, with resistance at $82.55. The stock is trading near its pivot level of $81.246, showing no clear breakout or breakdown.
Strong financial performance in Q3 2025, with revenue up 16.81% YoY, net income up 41.39% YoY, and EPS up 39.47% YoY.
Consistent analyst upgrades and raised price targets, with recent targets ranging from $80 to $
Positive growth outlook supported by international expansion and product innovation.
Favorable sentiment in the consumer staples sector as investors shift to defensive stocks.
Hedge funds and insiders are selling, with hedge fund selling increasing by 20619.83% and insider selling up 330.22% recently.
Short-term technical weakness, including a negative MACD and a 40% chance of a -5.15% decline in the next week.
Rich valuation metrics, as noted by analysts, which could limit upside in the near term.
Monster Beverage delivered strong financial results in Q3 2025, with revenue increasing by 16.81% YoY to $2.2 billion, net income rising by 41.39% YoY to $524.5 million, and EPS growing by 39.47% YoY to $0.53. Gross margin also improved to 55.73%, up 4.85% YoY, showcasing robust operational efficiency.
Analysts are bullish on MNST, with multiple firms raising price targets recently. Argus raised its target to $95, Morgan Stanley to $96, and Wells Fargo to $86, all maintaining Buy or Overweight ratings. Analysts highlight Monster's strong growth history, international expansion, and product innovation as key drivers for its premium valuation.
